Table 3.
Patients with treatment failure and subsequent management
| Patient | Organism(s) isolated | Initial medical managementa |
Receiving antibiotic therapy at time of failure | Criterion for treatment failureb | Microbiological failure | Rifampin resistance detected | Management of treatment failure | Outcome of retreatment | Time of follow-up after treatment failure (mo) | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parenteral antibiotic(s) | Duration of parenteral antibiotic(s) (days) | Oral antibiotic(s) | Duration of oral antibiotic(s) (mo) | |||||||||
| 1 | MRSA plus Escherichia coli | V, CTX | 52 | R, FA | 17 | Yes | 3 | No | No | Above-knee amputation | Free from subsequent failure | 19 |
| 2 | MR-CNS (2 different isolates) | V | 7 | R, FA | 1 | Yes | 1 | Yes | Yes | Two-stage exchange | Free from subsequent failure | 42 |
| 3 | MRSA plus Escherichia coli | V, M | 59 | R, FA, C | 7 | Yes | 1 | Yes | No | Life-long suppression with rifampin and fusidic acidc | Life-long antibiotic suppression | 30 |
| 4 | MRSA | V | 7 | R, FA | 6 | Yes | 2 | No | Yesd | Further debridement followed by clindamycin and amoxicillin for 24 mo | Developed sinus tract | 24 |
| 5 | MRSA | V | 14 | R, FA | 1 | Yes | 4 | No | No | Debridement and rifampin and fusidic acid for 22 mo | Free from subsequent failure | 24 |
| 6 | MRSA | V | 2 | R, FA | 4 | Yes | 1 | Yes | Yes | Two-stage exchange | Free from subsequent failure | 68 |
| 7 | MRSA | V | 12 | R, FA | 1 | Yes | 2 | No | No | Debridement and 6 mo ciprofloxacin | Free from subsequent failure | 74 |
| 8 | MRSA | V | 15 | R, FA | 1 | Yes | 1 | Yes | Yes | Resection arthroplasty | Free from subsequent failure | 4 |
| 9 | MRSA plus Enterococcus faecalis | V | 3 | R | 2e | No | 4 | No | No | Recommenced rifampin and fusidic acid for 15 mo | Free from subsequent failure | 36 |
V, vancomycin; CTX, ceftriaxone; M, meropenem; R, rifampin; FA, fusidic acid; A, amoxicillin; C, ciprofloxacin.
Criteria for treatment failure were as follows: 1, recurrence of same microorganism(s); 2, isolation of a different microorganism(s); 3, periprosthetic purulence observed; 4, development of sinus tract.
The patient presented with a new diagnosis of myasthenia gravis requiring prolonged intensive care unit admission and was too unwell for further surgical interventions.
MRSE (methicillin-resistant S. epidermidis) resistant to rifampin and fusidic acid was subsequently isolated from the patient.
All oral antibiotics were ceased due to acute renal failure/acute interstitial nephritis.